Medy-Tox (XKRX:086900) Other Operating Expense : ₩55,113 Mil (TTM As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Other Operating Expense?

Medy-Tox's Other Operating Expense for the three months ended in Dec. 2023 was ₩55,113 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩55,113 Mil.

Medy-Tox's quarterly Other Operating Expense increased from Jun. 2023 (₩0 Mil) to Sep. 2023 (₩0 Mil) and increased from Sep. 2023 (₩0 Mil) to Dec. 2023 (₩55,113 Mil).

Medy-Tox's annual Other Operating Expense increased from Dec. 2021 (₩26,227 Mil) to Dec. 2022 (₩32,465 Mil) but then declined from Dec. 2022 (₩32,465 Mil) to Dec. 2023 (₩29,980 Mil).

Medy-Tox Other Operating Expense Historical Data

The historical data trend for Medy-Tox's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Other Operating Expense Chart

Medy-Tox Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

36,553.45

42,027.06

26,227.16

32,464.92

29,979.60

Medy-Tox Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															55,789.35	-	-	-	55,112.57

Medy-Tox Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩55,113 Mil.

Medy-Tox Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Medy-Tox's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Medy-Tox (XKRX:086900) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885

Website

http://www.medytox.com

Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines